This Future Market Insights report examines the China First Aid Market for the period 2014 - 2020. The China market is not limited to Beijing and Shanghai anymore, with Tier 2 cities in China such as Suzhou emerging as prominent markets for first aid products in the country. This report focuses on the market trends and developments in Tier 1, 2 and 3 cities in China. On the basis of first aid products, the market in the country has been segmented into adhesive bandages, disinfectants and gauzes.
The report provides an overview of China’s economy, statistics and in-depth analysis about the healthcare industry in the country, healthcare expenditure, per capita income and wound rate, among others. The healthcare industry in the country is mainly driven by growing aging population and increasing household income.
The report covers China first aid market revenue split by product type, namely, revenue generated by adhesive bandage, disinfectant and gauzes product segment in 2014 and forecast till 2020. A detailed analysis of latest trends followed by major players is also included in the report.
Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-cn-659
Furthermore, the report offers detailed analysis of the adhesive bandages segment in China by prices (low-end adhesives bandages & high-end adhesive bandages), by material (plastic, cloth, paper and foam) and by purpose of use (special bandage, transdermal bandage and butterfly stiches).
Thereafter, the report provides an insight of the China disinfectant products segment. This section analyses market share held by key players and market share of various types of disinfectants (antiseptic liquid, spays & wipes). This section also covers key online & offline promotional strategies used by market participants to attract customers.
Succeeding section of the FMI report provides in-depth information about the China gauzes segment, by price (low & high end gauzes) and by gauze type (woven & non-woven). Cross segmental analysis (low- and high-end gauzes in woven and non-woven segments) is also covered in this section.
The section that follows offers price point analysis of each product segment (adhesive bandage, disinfectant and gauzes) in 2014 & forecast till 2020.
All the above mentioned product segments are further covered on basis of revenue generated by each product segment in Tier 1 ,2 and 3 cities in China.
This is proceeded by a section that highlights revenue generated by each product segment by sales channel, namely online and offline. The report also considers sub-segments in offline channels (hypermarket and supermarket, convenience stores, drugstores and pharmacies).
This section also covers cross segmental analysis of each retail channel by Tier 1, 2 and 3 cities.
Key feature of this report is analysis of all key China first aid market segments, sub-segments, regional adoption and verticals revenue forecast in terms of absolute dollar. This is usually overlooked while forecasting the market. However, absolute $ opportunity is critical in assessing the level of opportunity that a market player can look to achieve and also helps identify potential resources from a sales and delivery perspective in the China’s first aid market.
The final section of the report provides the competitive landscape of the China first aid market which gives audiences a dashboard view based on presence of key players in the market, their product portfolios and key differentiators.
To Buy This Research Report @ https://www.futuremarketinsights.com/checkout/659
The report covers information regarding key players in the various product segments, namely, disinfectant, adhesive bandage and gauze. This section is primarily designed to provide clients with an objective & detailed comparative assessment of key providers specific to various market segments in the China’s first aid market.
Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and success in the China first aid marketplace. Detailed profiles of the major players in the market are also included within the scope of the report to evaluate their long- and short-term strategies, key offerings and recent developments in the China first aid market. Key competitors covered in the report are Johnson & Johnson, Covidien, Winner Medical, Reckitt Benckiser and Yunnan Baiyao.
The report also includes profiles of key retailers in the China first aid market such as Watson, Mannings, 7Eleven, Nepstar and Hualian.
ABOUT US:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
CONTACT US:
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) Forecast to 2027Market ScopeMarket Research Future (MRFR) studied the global lymphedema treatment market 2020 for the analysis tenure till 2025.
The rise in research activities for the development of new drugs to treat lymphedema drawing funds from top-notch investors for the commercialization of novel drug formulations.
The existing treatment of lymphedema i.e., surgery and radiation therapy, are not effective, as reappearance of lymphedema is often reported after months or years.
Thus, the inclination towards the need for effective drug for treating lymphedema can add impetus to the market growth.
Favorable reimbursement policies, along with the support of government for affording treatment, are additional causes that can benefit the lymphedema treatment market.
On the contrary, limited availability of treatment options for lymphedema can hinder the market rise.
